Navigation Links
Immunosuppressive drug shows promise in treatment of eye disorder

It is a routine practice to prescribe drugs called immunosuppressant to transplant patients to prevent the transplanted organs from being rejected. The medical community has only been interested in worrying about the problems caused due to immunosuppression. Looking at the other side of the coin, there seems to be benefits as well.//

It has been found out that the immunosuppressive drug mycophenolate mofetil, used to prevent rejection of transplanted hearts, kidneys and livers, may also be effective in controlling inflammatory eye diseases. "The drug seemed to be effective even in patients who had failed treatment from other immunosuppressive drugs," says lead author Jennifer E. Thorne, M.D., an assistant professor of ophthalmology.

Physicians gave the drug to 84 patients, of whom 61 percent had uveitis (intraocular inflammation), 17 percent had scleritis (inflammation of the outer wall of the eye), 11 percent had mucous membrane pemphigoid (a condition causing scarring of the eyelids) and 11 percent had inflammation behind the eye or in other areas.

Patients took two pills each morning and two each evening, for a total dose of 2 grams daily. Thirty-six patients (43 percent) already had been treated with at least one other immunosuppressive drug.

The results revealed that 81 patients (97 percent) had control of their ocular inflammation after one month of treatment. Eighty-two percent of patients had control of their inflammation and were able to taper their dose of the steroid prednisone to 10 or fewer milligrams daily.

Side effects such as stomach upset or mild diarrhoea warranted the withdrawal of seven patients from the study. However, these side effects can be minimized by reducing the dosage of the drug in most of the cases, which offers a new ray of hope in the treatment of eye disorder.


'"/>




Page: 1

Related medicine news :

1. Immunosuppressive Action Of Fungal Metabolite - Gliotoxin
2. A Newly Identified Immunosuppressive Protein in Rheumatoid Arthritis
3. Gene Therapy shows promise in treating Hemophilia
4. Leukemia pill shows promise against stomach cancer
5. Stent shows promise in keeping arteries open
6. Drug to treat lung cancer shows promise
7. Latest drug shows promise in multiple myeloma
8. AIDS vaccine falls short but shows some promise
9. SARS vaccine shows promise in Animal Testing
10. Study shows that interventions from health workers can bring about changes in asthma causes
11. Research shows steady rise in allergic diseases
Post Your Comments:
(Date:11/21/2008)...e remains a mysteryswept into Athens. The walled G...s and refugees of the war then raging between Athe...ial order broke down. Over the next three years, t...of its population. It lost the war too. The Plague...Golden Age of Greece. , The Plague of Athens is...
(Date:11/21/2008)... Symmetry Medical Inc. (NYSE: SMA ), a leading i...opedic device industry and other medical markets, ... Chief Executive Officer, and Fred L. Hite, Senior...cheduled to present at the 20th Annual Piper Jaffr...otel on Wednesday, December 3, 2008 at 12:30 p.m. ...
(Date:11/21/2008)...ow can moss help us to treat Alzheimer,s disease? ...evolution? Can genetic studies of snapdragon popu...? What can quail teach us about human aging, repr...f choanoflagellates unravel the origins of animals...gy, scientists are increasing the array of experim...
(Date:11/21/2008)...t announcement, Governor,Schwarzenegger recommend...uxury" items such as veterinary services, which is...population. Animal welfare advocates across the s... to take action and contact the,governor and stat...anion animals are family members and taking care o...
Breaking Medicine News(10 mins):Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4Health News:A new world of research possibilities with 'Emerging Model Organisms' 2Health News:A Recommended Sales and Use Tax Proposed by Governor Schwarzenegger Will Tax Veterinary Services, Says Social Compassion in Legislation 2Health News:A Recommended Sales and Use Tax Proposed by Governor Schwarzenegger Will Tax Veterinary Services, Says Social Compassion in Legislation 3
...ychology and Aging had found that less volume of w...me old age people is the cause of decline in brain...ecline in brain activity in the old people is not ...white matter (frontal lobe) of the brain. Study fo...
...ms haunting India over the past decade. The proble...ded as many as 459 AIDS related deaths over the pa...ed during the period between January//, 2002 and S...ected in the state. Furthermore, 641 persons were ...
...to the low life expectancy of Scottish people who ...e lowest in United Kingdom where the countries ave...d 81 years for women//. The low life expectancy of...is said to be due to increased smoking and lack of...
...s not enough, bird flu alert has been sounded in t...rned not to buy and accept birds//. Migratory bird...said adding, the Wildlife Department is working to...ot confirmed in India and also in Jammu and Kashmi...
Other Medicine News:Health News:Orissa found to be worst affected by the killer disease, AIDS 2
(Date:11/19/2008)... Study did not achieve statistical significance ,...Call/ -- Pharmos Corporation (Nasdaq: PARS ) tod...ial of its topical NanoEmulsion (NE) drug delivery...lamine. , , The multi-center, randomized, d...the safety and efficacy of the Company,s 3% Diclof...
(Date:11/18/2008)...vember 19 NeuroDiscovery... provider and drug development Company,and Sosei...65), a leading,international biopharmaceutical co...enting further pivotal pre-clinical efficacy data ... potential therapy for neuropathic pain and has,s...
(Date:11/18/2008)... study will enroll newly diagnosed, elderly AML pa...wire/ -- Celator Pharmaceuticals today announced t...ized Phase 2 clinical study of CPX-351 (Cytarabine... newly diagnosed acute myeloid leukemia (AML). , ...dman, MD at the Weill Medical College of Cornell ...
(Date:11/12/2008)... Shares Award with James D. Watson, Marilyn & Jame...Event, ROCKVILLE, Md., Nov. 12 /PRNewswire-USNews...dent of the J. Craig Venter Institute (JCVI), was,...rbor Laboratory (CSHL) on,November 6th at a gala e...ouble Helix Medal along with Dr. James D.,Watson f...
Breaking Medicine Technology:Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 3J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory 2OncoGenex Pharmaceuticals to Release Third Quarter Financial Results 8895 1OncoGenex Pharmaceuticals to Release Third Quarter Financial Results 8895 2Rubber Rocks Staying Alive Unveils Furry Ads to Promote Safe Sex 28807 1Rubber Rocks Staying Alive Unveils Furry Ads to Promote Safe Sex 28807 2Rubber Rocks Staying Alive Unveils Furry Ads to Promote Safe Sex 28807 3Rubber Rocks Staying Alive Unveils Furry Ads to Promote Safe Sex 28807 4Rubber Rocks Staying Alive Unveils Furry Ads to Promote Safe Sex 28807 5Rubber Rocks Staying Alive Unveils Furry Ads to Promote Safe Sex 28807 6Office Zone Announces New Line of 26apos 3BSafer 26apos 3B Paper Shredders 28803 1Office Zone Announces New Line of 26apos 3BSafer 26apos 3B Paper Shredders 28803 2EarthSearch Communications International Joins Motorola 26apos 3Bs Enterprise Mobility Business PartnerSelect Program 28799 1EarthSearch Communications International Joins Motorola 26apos 3Bs Enterprise Mobility Business PartnerSelect Program 28799 2
...E, Calif., June 04, 2007 /PRNewswire-FirstCall/ --...d positive Phase 2,results for the treatment of ho...nd seventeen women were enrolled in the company,s,...e 2 trial.,Postmenopausal women with 50 or more mo...zed to one of three treatment groups receiving,MF1...
..., Conn., June 04, 2007 /PRNewswire-FirstCall/ -- V...ted updated clinical,data in a poster session at t...Clinical Oncology (ASCO) on its lead anticancer ag...n a Phase II trial in,patients with relapsed or re...ial evaluates Cloretazine(R) (VNP40101M) in two,se...
Other Medicine Technology:Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 2Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 3Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 4Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 5Vion Pharmaceuticals Presents Updated Clinical Data from a Phase II,trial of Cloretazine (VNP40101M) in Patients with Relapsed or,Refractory Small Cell Lung Cancer 2Vion Pharmaceuticals Presents Updated Clinical Data from a Phase II,trial of Cloretazine (VNP40101M) in Patients with Relapsed or,Refractory Small Cell Lung Cancer 3Vion Pharmaceuticals Presents Updated Clinical Data from a Phase II,trial of Cloretazine (VNP40101M) in Patients with Relapsed or,Refractory Small Cell Lung Cancer 4
Bulb Direct has been selling replacement bulbs on the Internet since 1996, and we are extremely proud of our 100% satisfaction guarantee. Check out our catalog of replacement bulbs and see our discou
Bulb Direct has been selling replacement bulbs on the Internet since 1996, and we are extremely proud of our 100% satisfaction guarantee. Check out our catalog of replacement bulbs and see our discou
Bulb Direct has been selling replacement bulbs on the Internet since 1996, and we are extremely proud of our 100% satisfaction guarantee. Check out our catalog of replacement bulbs and see our discou
Bulb Direct has been selling replacement bulbs on the Internet since 1996, and we are extremely proud of our 100% satisfaction guarantee. Check out our catalog of replacement bulbs and see our discou
Medicine Products: